These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9261939)

  • 1. Further evaluation of the safety and protective efficacy of live attenuated hepatitis A vaccine (H2-strain) in humans.
    Mao JS; Chai SA; Xie RY; Chen NL; Jiang Q; Zhu XZ; Zhang SY; Huang HY; Mao HW; Bao XN; Liu CJ
    Vaccine; 1997 Jun; 15(9):944-7. PubMed ID: 9261939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of live attenuated hepatitis A virus vaccine (H2 strain) in humans.
    Ran LA; Wang DZ; Duan QY; Yan TY; Liu QL; Luo YG; Yang DZ; Yang DF; Xiao Z; Xie QJ
    Chin Med J (Engl); 1993 Aug; 106(8):604-7. PubMed ID: 8222910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protective efficacy of H2 strain live attenuated hepatitis A vaccines in an outbreak of hepatitis A].
    Zhao Y; Meng Z; Guo J; Wang X; Duo C; Liu H; Yao J; Chai S; Zhu H; Xu Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May; 34(3):144-6. PubMed ID: 11860920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunogenicity and efficacy trials of live attenuated hepatitis A vaccines].
    Xu Z; Li R; Meng Z
    Zhonghua Yi Xue Za Zhi; 1998 Apr; 78(4):254-6. PubMed ID: 10923477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers.
    Midthun K; Ellerbeck E; Gershman K; Calandra G; Krah D; McCaughtry M; Nalin D; Provost P
    J Infect Dis; 1991 Apr; 163(4):735-9. PubMed ID: 1849160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term immunogenicity and effectiveness of live attenuated hepatitis A vaccine (H2-strain)-a study on the result of 15 years' follow up].
    Zhuang FC; Mao ZA; Jiang LM; Wu J; Chen YQ; Jiang Q; Chen NL; Chai SA; Mao JS
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1332-5. PubMed ID: 21223658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiological effects of live attenuated hepatitis A vaccine (H(2)-strain): results of A 10-year observation].
    Zhuang F; Jiang Q; Gong Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Jun; 22(3):188-90. PubMed ID: 11860874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with an inactivated hepatitis A vaccine.
    Clemens R; Safary A; Hepburn A; Roche C; Stanbury WJ; André FE
    J Infect Dis; 1995 Mar; 171 Suppl 1():S44-9. PubMed ID: 7876648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis A vaccine.
    Med Lett Drugs Ther; 1995 Jun; 37(950):51-2. PubMed ID: 7760768
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunogenecity of hepatitis A vaccine in children below 2 years of age.
    Mittal SK; Rastogi A
    Indian Pediatr; 1999 Jan; 36(1):97. PubMed ID: 10709135
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate.
    Sjogren MH; Purcell RH; McKee K; Binn L; Macarthy P; Ticehurst J; Feinstone S; Caudill J; See A; Hoke C
    Vaccine; 1992; 10 Suppl 1():S135-7. PubMed ID: 1335645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
    Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z
    Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent efficacy of live attenuated hepatitis A vaccine (H2-strain) after a mass vaccination program.
    Zhuang FC; Qian W; Mao ZA; Gong YP; Jiang Q; Jiang LM; Chen NL; Chai SA; Mao JS
    Chin Med J (Engl); 2005 Nov; 118(22):1851-6. PubMed ID: 16313838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
    Sandman L; Davidson M; Krugman S
    J Infect Dis; 1995 Mar; 171 Suppl 1():S50-2. PubMed ID: 7876649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A field evaluation of the epidemiological efficacy of an attenuated live hepatitis A vaccine (H2 strain)].
    Zhang Y; Liu X; Ma J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Nov; 35(6):387-9. PubMed ID: 11840766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
    Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis A vaccine.
    Bader TF
    Am J Gastroenterol; 1996 Feb; 91(2):217-22. PubMed ID: 8607483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
    Dagan R; Greenberg D; Weber F
    Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of an inactivated hepatitis A vaccine in children 2 to 5 years old.
    Arístegui J; Morales JL; Dal-Ré R; González A; Gallego MS; Garrote E
    Infection; 1995; 23(5):334-8. PubMed ID: 8557400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reactivity and immunogenicity of Havrix 360 vaccine for hepatitis A].
    Borcić B; Kovac S; Mihaljević I; Dobrovsak-Sourek V; Ljubicić M
    Lijec Vjesn; 1996; 118(7-8):162-4. PubMed ID: 8965633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.